Bocunebart clinical trials
Also written Lu AG09222.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses bocunebart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- Lu AG09222
- 6
Studies by the year they started
6 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses bocunebart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedPhase 2H. Lundbeck A/SNCT06323928Written as Lu AG09222
- A Trial Investigating Lu AG09222 With Ubrogepant in Participants With MigraineCompletedPhase 1H. Lundbeck A/SNCT06578585Written as Lu AG09222
- A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedPhase 2H. Lundbeck A/SNCT05133323Written as Lu AG09222
- A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese ParticipantsCompletedPhase 1H. Lundbeck A/SNCT05304910Written as Lu AG09222
- A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass PollenCompletedPhase 1H. Lundbeck A/SNCT05126316Written as Lu AG09222
- A Single Dose Study of Lu AG09222 in a Headache Model With Healthy SubjectsCompletedPhase 1H. Lundbeck A/SNCT04976309Written as Lu AG09222
Codes
What other systems call bocunebart · ClinicalTrials.gg INT017536
- UNII (FDA) P457A8A6EHBOCUNEBARTOne source FDA
- NCI Thesaurus C215728BocunebartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | P457A8A6EH | BOCUNEBART | One source FDA |
| NCI Thesaurus | C215728 | Bocunebart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.